The life sciences industry is evolving, and technology advancements demand changes in how Regulatory functions operate. Accenture leads the next evolution by applying leading-edge solutions across the drug, biologics, and device lifecycle that unifies innovative technologies with compliance-focused processes.
Accenture’s gamut of regulatory services includes and is not limited to submission strategy, RIM system implementation and management, dossier and lifecycle management, publishing, IDMP assessments & data collection, tech & data strategy and roadmap, operating model optimization, health authority interaction management and submission authoring utilizing generative AI. Accenture tracks submissions from early drug development through submission, approval, and the end-to-end drug lifecycle.
Accenture helps life science companies capitalize on Intelligent Automation benefits that go beyond the tangible gains of cost, quality and productivity improvements.
